Research & Development

久久精品视频在线看15久久人人97超碰久久爱北京推进身份证等替代医院自行发放的实体就诊卡

發布時間︰

  曹襄又對雲哲道︰“阿信把火藥藏在什麼地方,你應該知道吧?”   曹襄萬萬沒有想到劉據居然會這樣說。久久精品视频在线看15   金日按住張安世準備倒酒的手,認真的道︰“說清楚,在我參加大比這件事情上,你們到底出了多大的力氣?”久久人人97超碰   “沒人知曉姑母與父皇爭吵的原因。”   雲瑯惱怒的甩掉手里的毛筆,憤憤的道︰“今天不殺人滅口是過不去了。”久久爱   “神仙住哪里?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo